Last updated on August 2016

A phase 3, randomized, placebo-controlled study to assess the efficacy and safety of an investigational medication versus placebo in patients with systemic sclerosis


Brief description of study

A phase 3, randomized, placebo-controlled study to assess the efficacy and safety of an investigational medication versus placebo in patients with systemic sclerosis

Detailed Study Description

Participation in this study would last approximately 96 weeks and would include approximately 12 visits to our office. Compensation may be provided for time and travel

Clinical Study Identifier: TX144768

Find a site near you

Start Over

Metroplex Clinical Research Center

8144 Walnut Hill Lane Suite 810 Dallas, TX USA
  Connect »